Media 280723

CTO Mr Craig Weller said on Aqua Phase studies revealing the absorption of CBD as more than 4 times greater than CBD in oil:
Bod has been sweating on the PK study for months. It needed to show improved bioavailability of 30% for the deal to proceed, it exceeded by a factor of 10, what this means is that if we ingest 100mg of CBD in oil, we will normally absorb 6-8% of the dose. With Aqua Phase, the CBD absorption is 32% This means we can either get a better response to the CBD or otherwise we can reduce the Aqua Phase dose – giving potentially less side effects and providing CBD raw material savings.
INVESTOR STREAM CHATS WITH: BOD CEO JO PATTERSON
31 Mar 2020
Published by: Investor Stream
BOD (ASX:BOD) AND SWISSE LAUNCH HEMP PRODUCT RANGE
30 Mar 2020
Published by: The Market Herald
REVENUE DOUBLES, LOSSES HALVED FOR BOD
28 Feb 2020
Published by: Business News Australia
INVESTOR STREAM CHATS WITH: BOD CEO JO PATTERSON
12 Feb 2020
Published by: Investor Stream
BOD GETS NEW IMPORT CLEARANCE FROM REGULATORS; SHARES LAG
11 Feb 2020
Published by: Stockhead
BOD BANKS ON 'LIPSTICK EFFECT' IF BREXIT BITES
13 Sep 2020
Published by: Australian Financial Review
Bod Australia gets green light to export growing medicinal cannabis product range
20 Nov 2019
Published by: Small Caps
Investor Stream chats with: BOD Australia CEO Jo Patterson (August 18, 2019) - YouTube
19 Aug 2019
Published by: Investor Stream
Cannabis could be the secret to anti-ageing — and a research collab between UTS and a medical marijuana company wants to get to the bottom of it
14 Aug 2019
Published by: Business Insider Australia
H&H Group sees potential for personalisation, probiotics and CBD in Asian beauty market
06 Aug 2019
Published by: Cosmetics Design Australia